Literature DB >> 21517982

Management of complications in renal replacement therapy.

Roman Shingarev1, Keith Wille, Ashita Tolwani.   

Abstract

Renal replacement therapies (RRTs) are frequently employed for treatment of patients suffering from acute kidney injury in the intensive care unit (ICU). Multiple modalities of RRT are currently available. These include intermittent hemodialysis, continuous renal replacement therapies, and hybrid therapies, such as sustained low-efficiency dialysis. Because of the high complexity of ICU patients, physicians must be aware of the limitations and complications of both intermittent and continuous dialysis modalities that can contribute to patient morbidity and mortality. In this article, we highlight the recognized complications of RRTs and the treatment approach to these complications.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517982     DOI: 10.1111/j.1525-139X.2011.00828.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  12 in total

1.  Citrate versus non-citrate anticoagulation in continuous renal replacement therapy: Results following a change in local critical care protocol.

Authors:  Samina R Chowdhury; Tom Lawton; Aaqid Akram; Robert Collin; James Beck
Journal:  J Intensive Care Soc       Date:  2016-11-01

2.  Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Jui-Yi Chen; Ying-Ying Chen; Heng-Chih Pan; Chih-Chieh Hsieh; Tsuen-Wei Hsu; Yun-Ting Huang; Tao-Min Huang; Chih-Chung Shiao; Chun-Te Huang; Kianoush Kashani; Vin-Cent Wu
Journal:  Clin Kidney J       Date:  2022-01-14

Review 3.  Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients.

Authors:  Welder Zamoner; Fernanda M de Freitas; Durval S S Garms; Mariele Gobo de Oliveira; André L Balbi; Daniela Ponce
Journal:  Pharmacol Res Perspect       Date:  2016-11-24

Review 4.  Optimal timing of renal replacement therapy initiation in acute kidney injury: the elephant felt by the blindmen?

Authors:  Chih-Chung Shiao; Tao-Min Huang; Herbert D Spapen; Patrick M Honore; Vin-Cent Wu
Journal:  Crit Care       Date:  2017-06-20       Impact factor: 9.097

5.  Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tai-Shuan Lai; Chih-Chung Shiao; Jian-Jhong Wang; Chun-Te Huang; Pei-Chen Wu; Eric Chueh; Shih-Chieh Jeff Chueh; Kianoush Kashani; Vin-Cent Wu
Journal:  Ann Intensive Care       Date:  2017-04-05       Impact factor: 6.925

Review 6.  Renal replacement therapies for infants and children in the ICU.

Authors:  Keia R Sanderson; Lyndsay A Harshman
Journal:  Curr Opin Pediatr       Date:  2020-06       Impact factor: 2.893

7.  Dialysis complications in AKI patients treated with extended daily dialysis: is the duration of therapy important?

Authors:  Bianca Ballarin Albino; André Luis Balbi; Daniela Ponce
Journal:  Biomed Res Int       Date:  2014-08-11       Impact factor: 3.411

8.  Mortality and Recovery of Renal Function in Acute Kidney Injury Patients Treated with Prolonged Intermittent Hemodialysis Sessions Lasting 10 versus 6 Hours: Results of a Randomized Clinical Trial.

Authors:  Bianca Ballarin Albino; Mariele Gobo-Oliveira; André Luís Balbi; Daniela Ponce
Journal:  Int J Nephrol       Date:  2018-08-13

9.  Impact of Early versus Late Initiation of Renal Replacement Therapy in Patients with Cardiac Surgery-Associated Acute Kidney Injury: Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials.

Authors:  Jie Cui; Da Tang; Zhen Chen; Genglong Liu
Journal:  Biomed Res Int       Date:  2018-12-18       Impact factor: 3.411

Review 10.  Timing of Initiation of Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury.

Authors:  José Agapito Fonseca; Joana Gameiro; Filipe Marques; José António Lopes
Journal:  J Clin Med       Date:  2020-05-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.